genetic polymorphisms

Effects of Clonality on the Genetic Variability of Rare, Insular Species: The Case of Ruta Microcarpa From the Canary Islands.

Published June 22, 2013

Effects of clonality on the genetic variability of rare, insular species: the case of Ruta microcarpa from the Canary Islands.

Ecol Evol. 2013 Jun; 3(6): 1569-1579
Meloni M, Reid A, Caujapé-Castells J, Marrero A, Fernández-Palacios JM, Mesa-Coelo RA, Conti… Continue reading →

Pharmacogenetic Study of Deferasirox, an Iron Chelating Agent.

Published June 6, 2013

Pharmacogenetic Study of Deferasirox, an Iron Chelating Agent.

PLoS One. 2013; 8(5): e64114
Lee JW, Kang HJ, Choi JY, Kim NH, Jang MK, Yeo CW, Lee SS, Kim H, Park JD, Park KD, Shin HY, Shin JG, Ahn HS… Continue reading →

[Ibuprofen: Safety and Efficiency of Its Use in Wide Clinical Practice].

Published May 31, 2013

[Ibuprofen: safety and efficiency of its use in wide clinical practice].

Ter Arkh. 2013; 85(3): 118-24

The paper presents data on the pharmacokinetics of the nonsteroidal anti-inflammatory drug ibuprofen and a review of the evidence base that suggests its… Continue reading →

Genetic Mediators of Neurocognitive Outcomes in Survivors of Childhood Acute Lymphoblastic Leukemia.

Published May 9, 2013

Genetic Mediators of Neurocognitive Outcomes in Survivors of Childhood Acute Lymphoblastic Leukemia.

J Clin Oncol. 2013 May 6;
Krull KR, Bhojwani D, Conklin HM, Pei D, Cheng C, Reddick WE, Sandlund JT, Pui CH

PURPOSESurvivors of childhood acute lymphoblastic… Continue reading →

The KCNH2 Genetic Polymorphism (1956, C>T) Is a Novel Biomarker That Is Associated With CCB and ?,?-ADR Blocker Response in EH Patients in China.

Published April 25, 2013

The KCNH2 Genetic Polymorphism (1956, C>T) Is a Novel Biomarker That Is Associated with CCB and ?,?-ADR Blocker Response in EH Patients in China.

PLoS One. 2013; 8(4): e61317
He F, Luo J, Luo Z, Fan L, He Y, Zhu D, Gao J, Deng… Continue reading →

Impact and Cost-Effectiveness of a Universal Strategy to Promote Physical Activity in Primary Care: Population-Based Cohort Study and Markov Model.

Published April 12, 2013

Impact and cost-effectiveness of a universal strategy to promote physical activity in primary care: population-based Cohort study and Markov model.

Eur J Health Econ. 2013 Apr 10;
Gulliford MC, Charlton J, Bhattarai N, Charlton C, Rudisill C

BACKGROUND: This… Continue reading →

Recognising the Symptoms: How Common Are Eating Disorders in Pregnancy?

Published March 16, 2013

Recognising the Symptoms: How Common Are Eating Disorders in Pregnancy?

Eur Eat Disord Rev. 2013 Mar 14;
Easter A, Bye A, Taborelli E, Corfield F, Schmidt U, Treasure J, Micali N

OBJECTIVES: This study aimed to investigate eating disorder… Continue reading →

Comment on “a New Electrocardiogram Finding for Massive Pulmonary Embolism: ST Elevation in Lead aVR With ST Depression in Leads I and V4 to V6”

Published March 13, 2013

Comment on “A new electrocardiogram finding for massive pulmonary embolism: ST elevation in lead aVR with ST depression in leads I and V4 to V6”

Am J Emerg Med. 2013 Mar 8;
Kukla P, Bryniarski L, Jastrz?bski M, Krupa… Continue reading →

Alteplase for the Treatment of Catheter Occlusion in Pediatric Patients (March).

Published March 7, 2013

Alteplase for the Treatment of Catheter Occlusion in Pediatric Patients (March).

Ann Pharmacother. 2013 Mar 5;
Anderson DM, Pesaturo KA, Casavant J, Ramsey EZ

OBJECTIVE:To review the literature pertaining to the efficacy of alteplase for restoration of patency of… Continue reading →

Cytochrome P450 2E1 Gene Polymorphisms/Haplotypes and Anti-Tuberculosis Drug-Induced Hepatitis in a Chinese Cohort.

Published March 6, 2013

Cytochrome P450 2E1 Gene Polymorphisms/Haplotypes and Anti-Tuberculosis Drug-Induced Hepatitis in a Chinese Cohort.

PLoS One. 2013; 8(2): e57526
Tang S, Lv X, Zhang Y, Wu S, Yang Z, Xia Y, Tu D, Deng P, Ma Y, Chen D, Zhan… Continue reading →